BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
BLCM
Delisted
BLCM was delisted on the 1st of June, 2023.
30 hedge funds and large institutions have $5.13M invested in Bellicum Pharmaceuticals, Inc. in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
30
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$738K | |
| 2 | +$90K | |
| 3 | +$89.7K | |
| 4 |
LPL Financial
San Diego,
California
|
+$42K |
| 5 |
Morgan Stanley
New York
|
+$13.1K |
Top Sellers
| 1 | -$102K | |
| 2 | -$67.5K | |
| 3 | -$60.7K | |
| 4 |
Bank of New York Mellon
New York
|
-$50K |
| 5 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
-$50K |